NIH, NCI face devastating cuts in debt ceiling fight; We must rally for biomedical research

Judith Kleinerman receives ASH Exemplary Service Award

The American Society of Hematology will recognize Judith Kleinerman as the recipient of the 2024 ASH Exemplary Service Award.

November 15, 2024

Vol.50 No.43

Clinical Roundup

Preclinical data suggest WRN inhibitor may be viable treatment for MSI-H tumors

Preclinical data on a development candidate, NTX-452, a novel Werner syndrome helicase inhibitor, was presented at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, by Nimbus Therapeutics.

October 25, 2024

Vol.50 No.40

In Brief

Daniel Drucker awarded 21st AACR-Irving Weinstein Foundation Distinguished Lectureship

Daniel J. Drucker will be awarded the American Association for Cancer Research 21st AACR-Irving Weinstein Foundation Distinguished Lectureship during the 2025 AACR annual meeting, to be held April 25-30 in Chicago, Illinois.

October 11, 2024

Vol.50 No.38

In Brief

Qure.ai completes $65M Series D funding round

Qure.ai has announced the completion of a $65 million Series D funding round. The investment will expedite expansion into the U.S. market and other countries, increase investment in foundational AI models, and enable complementary med-tech company acquisitions.

October 04, 2024

Vol.50 No.37

Guest Editorial

Group chairs propose funding strategy to jump-start correlative studies

The National Academy of Medicine recognized the value of correlative science in publicly funded clinical trials in 2010, recommending “the incorporation of innovative science into cancer clinical trials through the support and use of biorepositories.”

September 20, 2024

Vol.50 No.35

By Peter J. O'Dwyer

AACR progress report highlights AI’s role in research and clinical care
Obstacles to progress include systemic disparities and dwindling appropriations

Artificial intelligence is starting to transform life sciences by accelerating drug discovery and development, optimizing clinical trials, and creating personalized treatments for cancer patients, speakers said at the Sept. 18 unveiling of the American Association for Cancer Research 2024 Cancer Progress Report.

September 20, 2024

Vol.50 No.35

By McKenzie Prillaman

NIH, NCI face devastating cuts in debt ceiling fight; We must rally for biomedical research

YOU MAY BE INTERESTED IN

Judith Kleinerman receives ASH Exemplary Service Award

Preclinical data suggest WRN inhibitor may be viable treatment for MSI-H tumors

Daniel Drucker awarded 21st AACR-Irving Weinstein Foundation Distinguished Lectureship

Qure.ai completes $65M Series D funding round

Group chairs propose funding strategy to jump-start correlative studies

AACR progress report highlights AI’s role in research and clinical care
Obstacles to progress include systemic disparities and dwindling appropriations

Renew today!

Subscriber content

Never miss an issue!

Login

NIH, NCI face devastating cuts in debt ceiling fight; We must rally for biomedical research

YOU MAY BE INTERESTED IN

Judith Kleinerman receives ASH Exemplary Service Award

Preclinical data suggest WRN inhibitor may be viable treatment for MSI-H tumors

Daniel Drucker awarded 21st AACR-Irving Weinstein Foundation Distinguished Lectureship

Qure.ai completes $65M Series D funding round

Group chairs propose funding strategy to jump-start correlative studies

AACR progress report highlights AI’s role in research and clinical careObstacles to progress include systemic disparities and dwindling appropriations

Never miss an issue!

Login

AACR progress report highlights AI’s role in research and clinical care
Obstacles to progress include systemic disparities and dwindling appropriations